iXCells Biotechnologies

Just Launched! Our Human iPSC-Derived Cortical GABAergic Neurons 2.0 deliver high purity, functionality, and long-term stability. These neurons exhibit endogenous GABA neurotransmitter release and express key inhibitory markers, including GAD₆₇, vGAT, and Parvalbumin. They have been validated for long-term cultures (40+ days) and electrophysiological assays. With batch-to-batch consistency, they provide reproducible results across diverse applications, including CNS disease modeling and drug discovery. Curious to see how our GABAergic Neurons perform? Explore the data today and discover how they can benefit your research: https://lnkd.in/gJiEx7bG #Neuroscience #iPSC #Reproducibility #Data #Launch #Research #DrugDiscovery #StemCells #CNSResearch #Electrophysiology #Neurobiology #DrugScreening #sfn24 #productlaunch #neurodegenerativediseases #GABAergicneurons #sandiegobiotech #bostonbiotech 

We know how crucial reproducibility, long-term functionality, and data consistency are in CNS research. That’s why we developed our Human Cortical GABAergic Neurons 2.0—to provide the reliability you need for your most important studies. Whether you're focused on Autism, Huntington’s Disease, Parkinson’s Disease, and SLC6A1. These neurons are designed to support your research with: Key benefits: 1. High purity & maturity, expressing key markers like GAD67, vGAT, and Parvalbumin 2. Increased release of endogenous GABA neurotransmitters, ensuring functional relevance in disease models 3. Proven 40+ days of stability for long-term culture studies 4. Easy integration into co-culture systems with astrocytes, dopaminergic, and glutamatergic neurons Curious about how GABAergic Neurons 2.0 could fit into your research? Let’s connect and chat more! Feel free to DM us with any questions. #Neuroscience #iPSC #Reproducibility #Data #Launch #Research #DrugDiscovery #StemCells #CNSResearch #Electrophysiology #Neurobiology #DrugScreening #sfn24 #productlaunch #neurodegenerativediseases #GABAergicneurons #sandiegobiotech #bostonbiotech #SLC6A1 #Huntingtons

1 Day Left – Join the N=1 Collaborative Annual Meeting! iXCells Biotechnologies President and CSO Nianwei Lin will speak at the N=1 Collaborative Annual Meeting in Montreal tomorrow, and there’s still time to register! This event is a unique opportunity to dive deep into the latest advancements in personalized medicine for ultra-rare diseases. It will serve as a powerful platform for collaboration and innovation, bringing together diverse perspectives across the field. Whether you're an industry professional, researcher, or advocate, this is your chance to join the conversation shaping the future of N=1 therapeutics. 🌟 📅 Date: Tomorrow, October 5, 2024 📍 Location: Omni Hotel – Mont Royal, Montreal, Canada 🔗 Don’t miss your chance – register now! https://lnkd.in/gyN3RkdU #N1Collaborative #PersonalizedMedicine #UltraRareDiseases #raredisease #iXCellsBiotechnologies #Collaboration #ipsc #Innovation #individualizedmedicine

Looking for advanced cell models for neurodegenerative disease research? Explore our iPSC, iPSC-derived, and primary cell models designed for neurotoxicity assays, disease modeling, and in vitro pharmacology studies. Learn more: https://lnkd.in/gxnkwYV4 #iPSC #NeurodegenerativeDiseases #DiseaseModeling #DrugDiscovery #CRISPR #ALS #Parkinsons #CNSDiseases #Research

🔔 Starting Soon! Don't miss out on this opportunity to gain valuable insights into preclinical development for personalized therapy, featuring modalities like ASO, small molecule repurposing, and gene therapy. Register and join us in 20 minutes! https://lnkd.in/gJ2Ptc8y We look forward to seeing you there! #biotech #cellandgene #rarediseases #scientificadvancement #ResearchCollaboration #CellTechnology #GeneTherapy #CellTherapy #DrugDiscovery #PersonalizedMedicine #RareDiseases #GeneEditing #EngineeredCells #CRISPRCas9 #CellModels #patient #ipscs #Biotechnology #NeurodegenerativeDiseases #sandiego #webinar

We're thrilled to invite you to a special webinar with our President and Co-Founder, Dr. Nianwei Lin, as part of the N=1 Collaborative webinar series on July 15, 2024! In this session, Dr. Lin will share insights on preclinical development for personalized therapy, covering modalities like ASO, small molecule repurposing, and gene therapy, all using disease-relevant cell models. This is a fantastic opportunity for the scientific community, physicians, and patient advocacy groups to learn, connect, and engage with cutting-edge developments in personalized medicine. Looking forward to seeing you there! Date: July 15, 2024 Time: 9:30 - 10:30 AM US PT Register Here: https://lnkd.in/gJ2Ptc8y #biotech #cellandgene #rarediseases #scientificadvancement #ResearchCollaboration #CellTechnology #GeneTherapy #CellTherapy #DrugDiscovery #PersonalizedMedicine #RareDiseases #GeneEditing #EngineeredCells #CRISPRCas9 #CellModels #patient #ipscs #Biotechnology #NeurodegenerativeDiseases #sandiego #webinar

No need for fairy tales here—we're on the lookout for true professionals! Are you the next Key Account Manager for our commercial team? We have exciting opportunities in both San Diego 🌴 and Boston 🌆! Do you excel at managing primary and iPSC-derived cell-based applications within the life science market? Can you navigate through the worlds of cell biology research, drug discovery, biomarker identification, cell and immunotherapy, and related cell-based assays with ease? If you have the skills and drive to succeed without relying on magic, we want to meet you! Join iXCells Biotech and help us drive innovation and scientific discovery. Apply today https://lnkd.in/gA_nZkEW #BiotechJobs #KeyAccountManager #iPSC #CellBiology #JoinUs #iXCellsBiotech #SanDiegoJobs #BostonJobs

Today is Global ALS Awareness Day. At iXCells Biotechnologies, we stand with the ALS community, dedicated to advancing research and innovation for those impacted by this challenging disease. We believe in including the voices of those living with ALS/MND in the conversation about research and treatment. On this day, we join The International Alliance of ALS/MND Associations in recognizing the strength and resilience of those living with ALS/MND and their caregivers. Our commitment to accelerating scientific support and creating awareness is unwavering. Join us in our efforts to drive scientific progress and support the ALS community. #neuroscience #diseasemodeling #ALS #ALSMND #GlobalALSAwarenessDay #motorneurons

Unicorns are cool, but we’re not looking for mythical creatures. We need real people with real skills. Are you the one? We're searching for a Key Account Manager to join our commercial team in sunny San Diego! 🌞 Think you can juggle primary and iPSC-derived cell-based applications across life science market segments? Charm your way through cell biology research, drug discovery, biomarker identification, cell and immunotherapy, and related cell-based assays? If you’re a pro who can get the job done without any fairy dust, we want to hear from you! Bring your real-world magic to iXCells and help us push the boundaries of science. Ready to make an impact? Apply now! #biotechjobs #jobs #hiring #sales #jobopening #biotech #sandiegobiotech #bostonbiotech #sandiegojobs #bostonjobs #jobopportunity #hiring

We’re here at #BIO2024, and it’s all happening! 🌟 Come find us in San Diego—we’re excited to connect with you. iXCells Biotechnologies offers top-notch solutions for gene editing, reprogramming, differentiation, and disease modeling. We’re ready to support your research with our wide array of primary cells and iPSC lines. Since we’re local, why not visit our San Diego facility? It’s a great chance to see our cutting-edge technologies in action. Let’s chat during the conference or at our place—coffee’s on us! ☕️ #biotech #cellandgene #rarediseases #scientificadvancement #leadership #iXCells #innovation #ResearchCollaboration #CellTechnology #GeneTherapy #CellTherapy #DrugDiscovery #PersonalizedMedicine #GeneEditing #EngineeredCells #CRISPRCas9 #CellModels #STEMCells #Biotechnology #LifeSciences #ResearchandDevelopment #motorneurons #immunecells #immunooncology #preclinicalservices